Disclosure of Related Party Transactions for the half year ended September 30, 2022 | (Rs. in Crores) | |||||||||||||||||||||
Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or | ||||||||||||||||||||||
investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was | ||||||||||||||||||||||
undertaken. | ||||||||||||||||||||||
In case monies are due to either | ||||||||||||||||||||||
Details of the party (listed entity | Details of the counter party | party as a result of the | In case any financial indebtedness is incurred to make or give | Details of the loans, inter-corporate deposits, advances or investments | ||||||||||||||||||
/subsidiary) entering into the transaction | transaction | loans, inter-corporate deposits, advances or investments | ||||||||||||||||||||
Type of related party | Detail of other related | Value of the related | Remarks on | Value of transaction | ||||||||||||||||||
Sr. No. | party transaction as | approval by audit | during the reporting | Purpose for | Notes | |||||||||||||||||
Relationship of the | transaction | party transaction | approved by the | committee | period | Nature of | Nature (loan/ | which the funds | ||||||||||||||
audit committee | Opening | |||||||||||||||||||||
Closing Balance | indebtedness | Details of other | Cost | advance/ inter- | Interest | Secured/ | will be utilised | |||||||||||||||
counterparty with the | ||||||||||||||||||||||
Name | PAN | Name | PAN | balance as on | as on | (loan/ issuance of | Tenure | corporate | Tenure | by the ultimate | ||||||||||||
listed entity or its | indebtedness | Rate (%) | unsecured | |||||||||||||||||||
01.04.2022 | 30.09.2022 | debt/ any other | deposit/ | recipient of | ||||||||||||||||||
subsidiary | ||||||||||||||||||||||
etc.) | investment | funds (end- | ||||||||||||||||||||
usage) | ||||||||||||||||||||||
1 | Abbott India Limited | Abbott Capital India Limited., UK | Holding Company | Remittance of dividend | Remittance of dividend | Approved | 294.78 | |||||||||||||||
2 | Abbott India Limited | Abbott Healthcare Products Limited., U.K | Fellow subsidiary | Remittance of dividend | Remittance of dividend | Approved | 102.99 | |||||||||||||||
3 | Abbott India Limited | British Colloids Limited., U.K. | Fellow subsidiary | Remittance of dividend | Remittance of dividend | Approved | 40.43 | |||||||||||||||
4 | Abbott India Limited | Anisha Motwani | Independent Director | Director's Sitting Fees | Director's Sitting Fees | Approved | 0.08 | |||||||||||||||
5 | Abbott India Limited | Kaiyomarz Marfatia | Non-Executive Director | Director's Sitting Fees | Director's Sitting Fees | Approved | 0.04 | |||||||||||||||
6 | Abbott India Limited | Munir Shaikh | Chairman | Director's Sitting Fees | Director's Sitting Fees | Approved | 0.05 | |||||||||||||||
7 | Abbott India Limited | Shalini Kamath | Independent Director | Director's Sitting Fees | Director's Sitting Fees | Approved | 0.08 | |||||||||||||||
8 | Abbott India Limited | Sudahrshan Jain | Independent Director | Director's Sitting Fees | Director's Sitting Fees | Approved | 0.07 | |||||||||||||||
9 | Abbott India Limited | Vivek Kamath | Managing Director | Key Management | Key Management | Approved | 1.75 | |||||||||||||||
Personnel Remuneration | Personnel Remuneration | |||||||||||||||||||||
10 | Abbott India Limited | Rajiv Sonalker | Whole-Time Director | Key Management | Key Management | Approved | 1.12 | |||||||||||||||
Personnel Remuneration | Personnel Remuneration | |||||||||||||||||||||
11 | Abbott India Limited | Abbott India Limited Officers' Group | Other related party | Contributions made to | Contributions made to | 2 | Approved | 2.99 | Excess actual | |||||||||||||
Gratuity Scheme | Employee Benefit Funds | Employee Benefit Funds | transaction of Rs. 0.99 | |||||||||||||||||||
Cr is approved and | ||||||||||||||||||||||
rectified by the Audit | ||||||||||||||||||||||
Committee through | ||||||||||||||||||||||
omnibus approval. | ||||||||||||||||||||||
12 | Abbott India Limited | Abbott India Limited Employees' Group | Other related party | Contributions made to | Contributions made to | 0.5 | Approved | 0.39 | ||||||||||||||
Gratuity-cum-Life Assurance Scheme | Employee Benefit Funds | Employee Benefit Funds | ||||||||||||||||||||
13 | Abbott India Limited | Abbott India Limited (Legacy Solvay | Other related party | Contributions made to | Contributions made to | 1 | Approved | 0.75 | ||||||||||||||
Pharma India Limited) Employees' Group | Employee Benefit Funds | Employee Benefit Funds | ||||||||||||||||||||
Gratuity Scheme | ||||||||||||||||||||||
14 | Abbott India Limited | Abbott Diagnostics Medical Private | Fellow Subsidiary | Purchase of goods or | Purchase of goods or | 0.25 | Approved | 0.05 | ||||||||||||||
Limited., India | services | services | ||||||||||||||||||||
15 | Abbott India Limited | Abbott Diagnostics Medical Private | Fellow Subsidiary | Shared and Support | Shared and Support | 0.3 | Approved | 0.05 | 0.04 | 0.05 | ||||||||||||
Limited., India | Service Income | Service Income | ||||||||||||||||||||
16 | Abbott India Limited | Abbott GmbH, Germany | Fellow Subsidiary | Reimbursement of | Reimbursement of | 0.2 | Approved | 0.14 | ||||||||||||||
expenses | expenses | |||||||||||||||||||||
17 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Purchase of goods or | Purchase of goods or | 44.11 | Approved | 35.12 | 9.63 | 9.74 | - | |||||||||||
services | services | |||||||||||||||||||||
18 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Purchase of goods or | Purchase of goods or | 1.5 | Approved | 0.02 | ||||||||||||||
services | services | |||||||||||||||||||||
19 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Purchase of goods or | Purchase of goods or | 1.86 | Approved | 0.92 | ||||||||||||||
services | services | |||||||||||||||||||||
20 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Loan Licence charges | Loan Licence charges | 8.38 | Approved | 5.5 | ||||||||||||||
21 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Reimbursement of | Reimbursement of | 30 | Approved | 29.79 | 2.33 | 4.76 | ||||||||||||
expenses | expenses | |||||||||||||||||||||
22 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Reimbursement of | Reimbursement of | 20 | Approved | 16.6 | ||||||||||||||
expenses | expenses | |||||||||||||||||||||
23 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Reimbursement of | Reimbursement of | 1 | Approved | 0.48 | ||||||||||||||
expenses | expenses | |||||||||||||||||||||
24 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Reimbursement of | Reimbursement of | 0.25 | Approved | 0.11 | ||||||||||||||
expenses | expenses | |||||||||||||||||||||
25 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Sale of goods or services | Sale of goods or services | 46.46 | Approved | 34.17 | 13.44 | 12.68 | ||||||||||||
26 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Sale of goods or services | Sale of goods or services | 15 | Approved | 2.97 | ||||||||||||||
27 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Shared and Support | Shared and Support | 30 | Approved | 26.35 | 7.28 | 4.06 | ||||||||||||
Service Income | Service Income | |||||||||||||||||||||
28 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Reimbursement of | Reimbursement of | 0.8 | Approved | 0.46 | ||||||||||||||
expenses | expenses | |||||||||||||||||||||
29 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Reimbursement of | Reimbursement of | 0.2 | Approved | 0.12 | ||||||||||||||
expenses | expenses | |||||||||||||||||||||
30 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Deposit given | Deposit given | 0 | Approved | 0 | 14.77 | 14.77 | ||||||||||||
31 | Abbott India Limited | Abbott Healthcare Private Limited., India | Fellow Subsidiary | Deposit taken | Deposit taken | 0 | Approved | 0 | 0.45 | 0.45 | ||||||||||||
32 | Abbott India Limited | Abbott International LLC, USA | Fellow Subsidiary | Reimbursement of | Reimbursement of | 1 | Approved | 0.01 | 0.19 | |||||||||||||
expenses | expenses | |||||||||||||||||||||
33 | Abbott India Limited | Abbott International LLC, USA | Fellow Subsidiary | Reimbursement of | Reimbursement of | 0.2 | Approved | 0 | 4.69 | 0 | ||||||||||||
expenses | expenses | |||||||||||||||||||||
34 | Abbott India Limited | Abbott Laboratories (Singapore) Pte | Fellow Subsidiary | Reimbursement of | Reimbursement of | 1 | Approved | 0.44 | 0.07 | 0.32 | ||||||||||||
Limited., Singapore | expenses | expenses | ||||||||||||||||||||
35 | Abbott India Limited | Abbott Laboratories (Singapore) Pte | Fellow Subsidiary | Reimbursement of | Reimbursement of | 1 | Approved | 0.69 | 0.24 | 0.17 | ||||||||||||
Limited., Singapore | expenses | expenses | ||||||||||||||||||||
36 | Abbott India Limited | Abbott Laboratories GmbH, UAE | Fellow Subsidiary | Reimbursement of | Reimbursement of | 1 | Approved | 0.69 | 0.24 | 0.17 | ||||||||||||
expenses | expenses | |||||||||||||||||||||
37 | Abbott India Limited | Abbott Laboratories Limited, Thailand | Fellow Subsidiary | Reimbursement of | Reimbursement of | 0.5 | Approved | 0.24 | 0.18 | |||||||||||||
expenses | expenses | |||||||||||||||||||||
38 | Abbott India Limited | Abbott Products Operations AG. | Fellow Subsidiary | Purchase of goods or | Purchase of goods or | 93.66 | Approved | 53.04 | 103.97 | 138.04 | ||||||||||||
Switzerland | services | services | ||||||||||||||||||||
39 | Abbott India Limited | Abbott Products Operations AG. | Fellow Subsidiary | Purchase of goods or | Purchase of goods or | 223.65 | Approved | 179.45 | ||||||||||||||
Switzerland | services | services | ||||||||||||||||||||
40 | Abbott India Limited | Abbott Products Operations AG. | Fellow Subsidiary | Shared and Support | Shared and Support | 5 | Approved | 1.78 | 0.64 | 0.4 | ||||||||||||
Switzerland | Service Income | Service Income | ||||||||||||||||||||
41 | Abbott India Limited | Abbott Products Operations AG. | Fellow Subsidiary | Sale of goods or services | Sale of goods or services | 2 | Approved | 0 | 0.28 | 0 | ||||||||||||
Switzerland | ||||||||||||||||||||||
42 | Abbott India Limited | St. Jude Medical India Private Limited., | Fellow Subsidiary | Shared and Support | Shared and Support | 2 | Approved | 0.62 | 0.11 | 0.11 | ||||||||||||
India | Service Income | Service Income | ||||||||||||||||||||
Total | 534.82 | 835.33 | 158.37 | 185.9 |
Notes: Outstanding balances are balances as on date and but not due.
Digitally signed by
KRUPA KRUPA KETAN
KETAN ANANDPARA
ANANDPARA Date: 2022.11.25 15:07:31 +05'30'
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Abbott India Limited published this content on 25 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 November 2022 10:50:01 UTC.